About Lamet Pharma Private Limited
Data last updated:
Lamet Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24296MH2015PTC265853. Its GSTIN is 27AACCL8778R1ZD (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Rohini Jaiprakash Tiwari and Jaiprakash Bhagwatsharan Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2022, the company reported a revenue of ₹4.52 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹1.38 Cr (net margin -30.5%) and EBITDA of -₹1.22 Cr (EBITDA margin -27.1%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 16% over five years.
The company has about 89 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹55.55 Lakh on record. Court records list 9 cases involving the company, including 8 filed against it; 9 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lametpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address101 1st Floor B65 Building Jaydeep Shantinagar C.H.S.Limited Sector Shantinagar Meera, Road (E), Thane, Maharashtra, India – 401107
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Lamet Pharma Private Limited
The main business activity of Lamet Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Lamet Pharma Private Limited FY 2022 filings available
Lamet Pharma Private Limited reported revenue of ₹4.52 Cr (down 22% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Lamet Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 22% fall in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Lamet Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.22 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.38 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Lamet Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -27.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -30.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lamet Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Lamet Pharma Private Limited
Lamet Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Baylor Pharmaceutical Private Limited | ₹4.54 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Navi Mumbai, Maharashtra, India |
| Healing Hands & Herbs Private Limited | ₹4.54 Cr (FY 2024) | •••• | •••• | 91.0% | •••• | Pune, Maharashtra, India |
| Hychem Sainor Chemicals Private Limited | ₹4.53 Cr (FY 2024) | •••• | •••• | -13.0% | •••• | Hyderabad, Telangana, India |
| SGS Formulation Private Limited | ₹4.52 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Thiruvallur, Tamil Nadu, India |
| Medipaams India Private Limited | ₹4.52 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Mumbai, Maharashtra, India |
| Lamet Pharma Private Limited this company | ₹4.52 Cr (FY 2022) | •••• | •••• | -22.0% | •••• | Thane, Maharashtra, India |
| Denizen Pharmaceuticals India Private Limited | ₹4.51 Cr (FY 2025) | •••• | •••• | 125.0% | •••• | New Delhi, Delhi, India |
| Pacific Bioengineering Private Limited | ₹4.51 Cr (FY 2024) | •••• | •••• | -22.0% | •••• | Delhi, India |
| S N D Life Science Private Limited | ₹4.5 Cr (FY 2024) | •••• | •••• | 98.0% | •••• | Navi Mumbai, Maharashtra, India |
| Astrazen Pharmaceuticals Private Limited | ₹4.5 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Panchkula, Haryana, India |
| Nova Global Medicare Private Limited | ₹4.5 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Kolhapur, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Lamet Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Lamet Pharma Private Limited
Lamet Pharma Private Limited is audited by K. K. A. B. & Co. LLP for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K. K. A. B. & Co. LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Lamet Pharma Private Limited
Lamet Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohini Jaiprakash Tiwari | Director | 22 Jun 2015 | 11 Years 3 Months | Current |
| Jaiprakash Bhagwatsharan Tiwari | Director | 31 Jul 2015 | 11 Years 2 Months | Current |
Ownership and Shareholding of Lamet Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Lamet Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2020 | Others | ₹55.55 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Lamet Pharma Private Limited
Lamet Pharma Private Limited has 9 court cases on record: 8 filed against it, 1 where it is another party. All cases are pending. Status as checked between 30 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 8 | 9 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Haridwar, Uttarakhand | Criminal case | Filed against the company by Mestra Pharma Private Limited | Pending |
| District court, West, Delhi | Cheque dishonour complaint | Filed against the company by Foregen Healthcare Limited | Pending |
| District court, Haridwar, Uttarakhand | Criminal case | Filed against the company by Meril Pharma Pvt.Ltd | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed against the company by Park Pharmaceuticals | Pending |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company by Shree Mohmadzahis A Mal-Unimedia Pharmaceticals Pvt Ltd | Pending |
Full case history
All 9 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Lamet Pharma Private Limited
Lamet Pharma Private Limited has a workforce of 89 employees as of Apr 02, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Lamet Pharma Private Limited
Lamet Pharma Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Abhishek Kumar Bhansali ceased to be Director on 27 Jul 2020.
Credit Ratings, Litigation & Regulatory Alerts for Lamet Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lamet Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lamet Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Lamet Pharma Private Limited
Lamet Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCL8778R1ZD | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lamet Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lamet Pharma Private Limited
Lamet Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 June 2015 (11+ years old) and is registered under CIN U24296MH2015PTC265853.
Lamet Pharma reported revenue of ₹4.52 Cr for FY 2022 (down 22% YoY).
Lamet Pharma has 2 current directors:
- Rohini Jaiprakash Tiwari - Director
- Jaiprakash Bhagwatsharan Tiwari - Director
Lamet Pharma reported a net loss of ₹1.38 Cr (net margin -30.5%) and EBITDA of -₹1.22 Cr (EBITDA margin -27.1%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Lamet Pharma is -29% over three years and -16% over five years. In the latest year (FY 2022) revenue fell 22%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Lamet Pharma is 27AACCL8778R1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Lamet Pharma is U24296MH2015PTC265853. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lamet Pharma has 9 court cases on record: 8 filed against it. 9 are pending.
Lamet Pharma was incorporated on 22 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Lamet Pharma by revenue are Baylor Pharmaceutical Private Limited, Healing Hands & Herbs Private Limited, Hychem Sainor Chemicals Private Limited, SGS Formulation Private Limited, Medipaams India Private Limited and 5 more, all in the Pharma industry (Formulations).
Abhishek Kumar Bhansali ceased to be Director on 27 Jul 2020. Varun Rajkumar Parekh ceased to be Director on 27 Jul 2020. Jaiprakash Bhagwatsharan Tiwari was appointed as Director on 31 Jul 2015. Lamet Pharma has 4 board changes on record in total.